GoingToMeet

The importance of developing effective pharmacovigilance systems has been fuelled by an increased focus on drug safety and the ever-changing regulatory environment. This conference will tackle inspections, risk management, the use of Independent Data Monitoring Committees and establishing relationships with regulatory bodies along with a host of other key topics.

Reasons to Attend

• Hear the latest updates on various pharmacovigilance systems in the industry
• Explore ways in which you can optimise your own pharmacovigilance activities
• Discuss the potential impact of impending regulatory changes
• Network with industry associates and discuss experiences

Presentations Include:

• THE FUTURE OF PHARMACOVIGILANCE IN THE EU
Elmar Kroth, Head of Pharmacovigilance, German Medicines Manufacturers' Association

• INTERNAL AUDIT STRATEGY FOR PHARMACOVIGILANCE
Benoit Nauge, Senior Manager, Global Compliance Auditing, Amgen

• PHARMACOVIGILANCE INSPECTIONS BY NATIONAL HEALTH AUTHORITIES
Dominique Brunier, Head of Pharmacovigilance and Quality, Europe, Novartis